Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Adicet Bio Inc
(NQ:
ACET
)
1.390
-0.010 (-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adicet Bio Inc
< Previous
1
2
3
4
5
6
7
Next >
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
October 04, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
September 27, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
6 Analysts Have This to Say About Adicet Bio
June 27, 2023
Via
Benzinga
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study
May 18, 2023
Adicet Bio Inc (NASDAQ: ACET)
Via
Benzinga
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Announces Appointment of Katie Peng to the Board of Directors
July 11, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 30, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Analyst Downgrades Adicet Citing Uncertainty, Awaits Long-Term Data On Durability
June 27, 2023
JMP Securities downgraded Adicet Bio Inc (NASDAQ: ACET) to a Market Perform (from Market Outperform) and removed the
Via
Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
June 27, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
Dow Up Triple Digits As Consumer Confidence Increases
June 27, 2023
Stocks are on the rise this afternoon.
Via
Talk Markets
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
June 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
June 27, 2023
Via
Benzinga
US Stocks Higher; Durable Goods Orders Top Estimates
June 27, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% to 33,780.40 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 27, 2023
Via
Benzinga
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
June 27, 2023
Gainers
Via
Benzinga
Adicet Bio Stock Is Falling Premarket - Here's Why
June 27, 2023
Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 27, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!
Via
InvestorPlace
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 27, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
June 26, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 01, 2023
Via
Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
June 01, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
June 01, 2023
Via
Benzinga
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.